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Objectives: KLF8 is a member of KLF transcription factors which play an important tolr in oncogenesis. It is 
barely expressed in normal human epithelial cells but highly overexpressed in several types of human cancer cell 
lines. In the present study, we investigate the role of KLF8 in oral cancer and the effects of KLF8 knockdown via 
lentivirus mediated siRNA infection in human adenosquamos carcinoma CAL 27 cells.
Study Design: �e developed a vector-based siRNA expression system that can induce RNAi in CAL 27 oral can-
cer cells. Downregulation of KLF8 was confirmed by evaluating GFP expressions, RT-PCR and western blot anal-
ysis. Finally, the effects of KLF8 downregulation were analyzed by MTT assay and colony formation assays.
Results: The expression levels of KLF8 mRNA and proteins are reduced in CAL 27 cells that transfected with 21-
nt siRNA against KLF8. Lentivirus-mediated silencing of KLF8 reduces cell proliferation and colonies number, 
thereby indicating the role of KLF8 in cell proliferation and tumorigenesis.
Conclusions: These results strongly suggest that KLF8 is essential for growth of CAL 27 cancer cells. A better un-
derstanding of KLF8 function and processing may provide novel insights into the clinical therapy of oral cancer.
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The cancer occurring in the tissue of oral cavity or 
oropharynx is termed as oral cancer. Oral cancer is the 
sixth most common cancer worldwide and continuously 
represents a serious public health problem. It is the most 
common neoplasm of the head and neck with the annual 
incidence of new cases exceeds 300,000 worldwide (1). 
More than 90 percent of these tumors are squamos cell 
carcinomas, which arise from mucosal lining and char-
acterized by the simultaneous presence of glandular and 
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squamos component (2,3). All cases of oral cancer have 
shown an aggressive course with 60% of patients dying 
of disease. 
Surgical treatment is the mainstay of therapy for oral 
cancer patients, particularly in advanced stages of can-
cer. External beam radiation therapy and brachytherapy 
have been used as the primary modality for treating pa-
tients with early stage oral cancer (4). Despite therapeutic 
advances, including surgery, radiation, and chemother-
apy, the five-year survival rate for oral cancer has not 
improved significantly in the last three decades (5). This 
disappointing outcome strongly suggests that novel tar-
geted therapeutic agents are urgently needed to improve 
the treatment of patients diagnosed with oral cancer. 
Recent studies have clearly demonstrated advantages of 
RNA interference (RNAi) for the growth suppression 
and killing of cancer cells (6). RNAi is a phenomenon 
leading to post-transcriptional gene silencing (PTGS) 
after endogenous production or artificial introduction 
into a cell of small interfering double stranded RNA 
(siRNA) with sequences complementary to the genes. 
A number of gene products involved in carcinogenesis 
have already been explored as targets for RNAi, and 
RNAi targeting of molecules crucial for tumor-host in-
teractions and tumor resistance to chemo- or radiother-
apy has also been investigated. The silencing of gene 
associated with cancer by RNAi has generated signifi-
cant antiproliferative effects in cell-culture systems or 
in preclinical animal models (7). 
Krüppel-like factor 8 (KLF8) is a GT-box (CACCC) 
binding dual-transcription factor that has critical role in 
the regulation of the cell cycle progression, transforma-
tion and invasion. They belongs to the family Krüpple-
like zinc finger transcription factors, which in humans 
comprises at least 24 members (8). KLF8 has been dem-
onstrated as focal adhesion kinase (FAK) downstream 
effectors. Similar with FAK, KLF8 is ubiquitously 
expresses in invasive human cancer. KLF8 plays an 
important role in oncogenic transformation in several 
types of human cancer such as breast cancer, gastric 
cancer (9,10). KLF8 knockdown has been demonstrated 
to reduce the proliferation and invasion of human gas-
tric cells. However, effects of KLF8 downregulation in 
human oral cancer invasion have not been investigated. 
Hence, in this study we investigate the role of KLF8 
in oral cancer and the effects of KLF8 knockdown via 
lentivirus mediated siRNA infection in human adenos-
quamos carcinoma cells (CAL 27).
Matherial and Methods
1.1. Cell culture
Human adenosquamous carcinoma cell line CAL 27 
was bought from American Tissue Culture Collection 
(ATCC). Cells were grown in DMEM (Gibco) with 10% 
fetal bovine serum (FBS; Gibco), 100 μg/ml penicillin, 
and 100 μg/ml streptomycin in a humidified 37 °C incu-
bator with 5% CO2.
1.2. Design and construction of recombinant lentivirus
siRNA for KLF8 (5’-CAGCACTGTTTAATGACAT-3’) 
was inserted into the Plasmid pFH-L (Shanghai, Holly-
bio, China). Nonsilencing RNA (5’-TTCTCCGAACGT-
GTCACGT-3’) was used as control.
1.3. Lentivirus packing and infection
The lentivirus expression plasmid (pFH-L-KLF8 or con-
trol vector), together with pVSVG-I and pCMVΔR8.92 
plasmids that contained the imperative elements for vi-
rus packaging, were co-transfected into  293T cells with 
lipofectamine 2000, according to the manufacturer’s 
instructions for the generation of KLF8-shRNA len-
tivirus or control lentivirus. Lentivirus was harvested 
at 48 h post-transfection, centrifuged to get rid of cell 
debris, and then filtered through 0.45 µm cellulose ac-
etate filters followed by ultracentrifugation. For lenti-
virus infection, CAL 27 cells were grown to 70–80% 
confluence and infected with KLF8-shRNA lentivirus 
or control lentivirus at MOI of 10. In order to determine 
the infection efficiency, cells expressing GFP protein 
were observed using fluorescence microscopy (CKX41, 
Olympus) 5 days after infection.
1.4. Colony formation assay
In brief, 0.5 ml underlayers consisting of 0.8% agar me-
dium were prepared in six-well plates. Uninfected and in-
fected cells were trypsinized, centrifuged, resuspended 
in 0.4% agar medium (equal volumes of 0.8% noble agar 
and culture medium), and plated onto the top agar at 200 
cells per well. The cells were cultured for 14 days at 37°C. 
After cultured for 14 days, adherent cells were washed 
twice with PBS, fixed with 4% paraformaldehyde for 30 
min at room temperature. Colonies were visualized using 
a cell staining Giemsa solution (Chemicon) and counted 
under a fluorescence microscope.
1.5. Cell viability assay
Cell viability was determined by MTT reduction assay. 
In brief, uninfected and infected cells cells were seeded 
into 96-well plates at a density of 2 × 104 cells/well and 
incubated with serum free medium. After infection for 
1, 2, 3, 4 and 5 days, 100 µl of MTT (0.5 mg/ml final 
concentration) was added and incubation was continued 
for another 4 hours. MTT is used as an indicator of cell 
viability through its mitochondrial reduction to forma-
zan. Mitochondrial succinate dehydrogenase in live cells 
converts MTT into visible formazan crystals during in-
cubation. The formazan crystals were then solubilized 
in dimethylsulphoxide (DMSO) and the absorbance was 
measured at 595 nm by using enzyme-linked immuno-
sorbent assay (ELISA) microplate reader (Bio-Rad 680, 
Bio-Rad USA). Each assay was done in triplicate.
1.6. Reverse Transcriptase-Polymerase Chain Reaction 
(RT-PCR) analysis
Total RNA was extracted from cells by using TRIzol 
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reagent according to the manufacturer’s instruction. 
Reverse transcription was performed using MMLV 
Reverse Transcriptase and oligo (dT) primer. RT-PCR 
was conducted with the TAKARA TP800-Thermal 
Cycler DiceTM Real-Time System using SYBR green 
Master Mixture. All amplifications were performed 
in the final reaction mixture (20 µl). Single stranded 
cDNA was amplified by PCR with specific prim-
ers for KLF8 and GAPDH. Primer sequences used to 
amplify the containing were: KLF8 sense 5’-GGGT-
GTTTGGCTTCTTTGC-3’, KLF8 antisense 5’-GGCT-
GTGGTCTCATCTGC-3’; GAPDH sense: 5’-TGACT-
TCAACAGCGACACCCA-3’, GAPDH antisense: 5’-
CACCCTGTTGCTGTAGCCAAA-3’. The following 
PCR conditions were applied for all amplifications: 25 
cycles of denaturation at 94 °C for 30 s, annealing at 57 
°C for 30 s, and extended at 72 °C for 30 s. The resulting 
cDNA were separated by electrophoresis on 1% agarose 
gel for 15 minutes at 100 V, followed visualization under 
UV light after ethidium bromide staining. Band intensi-
ties were quantifies with Multi gauge Software (Fujifilm 
Life Science, Tokyo, Japan) and band of specific genes 
were normalized using GAPDH as references.
1.7. �estern blot analysis
Standard procedures were used for western blotting, 
where CAL 27 cells were washed with ice-cold PBS, 
scrapped and then lysed in RIPA buffer. Cell debris was 
removed by centrifugation followed by quick freezing 
of the supernatants. The protein concentrations were 
determined according to the Bicinchonic acid (BCA) 
assay. Total protein (30 µg) was subjected to 10 % 
SDS-PAGE gel electrophoresis and electro-blotted onto 
PVDF membrane. The membrane were blocked with 
5% bovine serum albumin (BSA) for 2 h and the incu-
bated with different antibodies which were used to de-
tect respective proteins using a chemiluminescent ECL 
assay kit, according to the manufacturer instructions. 
�estern blots were visualized using a LAS3000® Lu-
minescent image analyzer and protein expression was 
quantified by Multi gauge V3.0 software (Fujifilm Life 
Science, Tokyo, Japan).
Results 
2.1. Effect of lentivirus mediated si-KLF8 infection on 
KLF8 expression in CAL 27 cells
RNAi targeted gene which regulated cell proliferation 
could be an important way to prevent oral cancer cell in-
vasion. KLF8 have been shown to play significant roles 
in the regulation of the cell cycle progression, transfor-
mation and invasion. In this study, GFP containing len-
tivirus mediated infection of KLF8 siRNA in CAL 27 
cells was performed. The successful infection was con-
firmed by evaluating the expression of GFP. As shown 
in figure 1, the delivery efficiency of control lentivirus 
infected cells (Lv-shCon) and KLF8-shRNA lentivirus 
infected cells (Lv-shKLF8) are approximately 85% at 
multiplicity of infection (MOI) of 10. Most of CAL 27 
cells expressed GFP protein when observed under fluo-
rescence microscope 4 days-after infection, which sug-
gest that the infection is successful.
Furthermore, the effects of lentivirus-mediated silenc-
ing of KLF8 gene and protein expression were evalu-
ated by RT-PCR and western blot analysis, respectively. 
The level of GAPDH determined that equal quantities of 
KLF8 loaded in the gel. Quantitative analysis of KLF8 
mRNA level by densitometry revealed a significant de-
crease in Lv-shKLF8 (0.58-0.6 fold) compared to con-
trol and Lv-shCon (Fig. 1). Consistent with mRNA level 
result, western blot analysis showed that KLF8 protein 
expression in Lv-shKLF8 groups also downregulated. 
However, Lv-shCon group expressed KLF8 protein in 
almost similar level with the control group; suggesting 
that KLF8 specifically knocked down by KLF8-specific 
shRNA in CAL 27 cells. 
2.2. Effect of lentivirus mediated si-KLF8 infection on 
CAL 27 cells proliferation
In the present study, the standard MTT assay was used 
to assess the effect of the si-KLF8 on proliferation of 
CAL 27 cells (Fig. 2). Starting from the second day to 
fifth day after infection, Lv-shKLF8 infected CAL 27 
cells showed a decrease in proliferation relative to that 
of uninfected cells (con) and controls (Lv-shCon). These 
results strongly suggest that siRNA-mediated downreg-
ulation of KLF8 is specifically and effectively reduces 
proliferation of CAL 27 cells. 
2.3. Effect of lentivirus mediated si-KLF8 infection on 
colony forming capacity of CAL 27 cells
Colony formation is commonly used to assess the prolif-
erative capacity of cancer cells. In several studies, this 
capacity has been shown to indicate tumorigenic poten-
tial. Therefore, colony-forming capacity of uninfected 
cells, Lv-shCon, and Lv-shKLF8 infected cells were 
tested. The colony formation assay demonstrated that 
downregulation of KLF8 suppressed the colony-form-
ing capacity of CAL 27 cells (Fig. 3). Moreover, giemsa 
staining and fluorescence microscopy (14 days after 
infection) revealed that stable infection of Lv-shKLF8 
resulted in dramatic decrease in the number and size of 
colonies in CAL 27 cells (Fig. 3). Compared to the con-
trol (37 colonies) and Lv-shCon group (35 colonies), the 
cell number per colony of Lv-shKLF8 group were re-
duced to 22 colonies (Fig. 3). These results indicate that 
KLF8 is essential for growth of CAL 27 cancer cells.
Discussion
In some European and Southeast Asian countries, oral 
cancer prevails to be the leading form of cancer. Poor 
survival outcome with a probability of survival at 5 
years being less than 50 percent is seen in oral carcino-
ma diseases. High recurrence rate leading to treatment 
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Fig. 1. Down regulation of KLF8 in CAL 27 cells by siRNA. Transduction efficiency was assessed four days 
after infection at MOI of 10; magnification 200×. Light microscope (up); fluorescent microscope (bottom) (A). 
Total cellular RNA was extracted four days after infection and determined by RT-PCR analysis. Data was ex-
pressed as fold changes (B). Total cellular proteins was extracted and determined by western blot (C). GAPDH 
was used as control. Data represent the means of three independent experiments. Con: uninfected cells; Lv-
shCon: control lentivirus infected cells and Lv-shKLF8: KLF8-shRNA lentivirus infected cells.
Fig. 2. siRNA-mediated downregulation of KLF8 in reduces proliferation of CAL 27 cells. A growth curves 
of cells during five days evaluated by MTT assay. Data represent the means of three independent experiments. 
Con: uninfected cells; Lv-shCon: control lentivirus infected cells and Lv-shKLF8: KLF8-shRNA lentivirus 
infected cells.
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failure seems to be the major drawback in the patient 
treatment protocol (11). Therefore novel targeted ther-
apeutic methods such as gene therapies are opening a 
new way to improve the treatment of patients diagnosed 
with oral cancer. 
KLF8 is a member of KLF transcription factors which 
play an important role in oncogenesis.  KLF8 is barely 
expressed in normal human epithelial cells but highly 
overexpressed in several types of cancer cell lines es-
tablished from human patients, including ovarian, glio-
mas, breast, gastric and renal carcinomas (12). Various 
signaling pathways regulating KLF8 expression and its 
target genes associated with cancer have been identified. 
For example, KLF8 has been reported to transduce FAK 
to PI3K to AKT to SP1 signaling to up regulate cyclin 
D1 expression and enhance the cell cycle progression in 
ovarian cancer cell (13). Li et al. (16) reported the role of 
KLF8 in mediating Wnt to β-catenin signaling pathway 
to activate the transcription of c-Myc, cyclin D1 and 
Axin1 which promote HCC cell proliferation. In addi-
tion, KLF8 is necessary for gastric cancer cell survival 
and invasion. Furthermore, silencing of KLF8 may lead 
to cancer cell death (10). KLF8-knockdown by shRNA 
in U87 glioma cells has been reported to suppressed tu-
mor cell proliferation (14). However, silencing of KLF8 
has not been explored in oral cancer cells. 
In the present study, we have developed a vector-based 
siRNA expression system that can induce RNAi in CAL 
27 oral cancer cells. �e directed 21-nt siRNA against 
KLF8 in order to simultaneously suppress KLF8 ex-
pression. �e have shown that the expression levels of 
KLF8 mRNA and proteins are reduced in transfected 
cells. Lentivirus-mediated silencing of KLF8 reduces 
cell proliferation and colonies number, thereby indicat-
ing the role of KLF8 in cell proliferation and tumori-
genesis. These result, provide the first evidence for the 
potency of this transcription factor in human oral can-
cer. In agreement with our finding, several studies dem-
onstrated that knocking down KLF8 in the U87-MG 
glioma cells, 786-0 renal cells, and SGC-7091 gastric 
cancer cells, HCC hepatocellular carcinoma dramati-
cally inhibited the cells proliferation (10,14-16). KLF8-
siRNA has been reported to depress the cellular growth 
and invasion of 786-0, U87-MG and SGC-7091 cells in 
vitro. Flow cytometry results revealed that KLF8-siR-
NA could induce an increase in G0/G1 phase cells and 
induce cancer cell apoptosis (10). KLF8 knockdown in 
the cancer cells resulted in reduced xenografted tumor 
Fig. 3. Silencing of KLF8 suppressed the colony-forming capacity of CAL 27 cells. Colony-formation assays of unin-
fected cells (upper panels); Lv-shCon (lower panel) and Lv-shKLF8 (lowest panels) cells (A). All uninfected cells and 
infected cells were cultured for  14 days in the presence and the numbers of colonies were counted by Giemsa staining 
(magnification 200×). (B). Quantitative analysis of colony formation assay (C). Data represent the means of three inde-
pendent experiments. Con: uninfected cells; Lv-shCon: control lentivirus infected cells and Lv-shKLF8: KLF8-shRNA 
lentivirus infected cells.
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growth in nude mice with decreased expression of cyc-
lin D1 and Bcl-2, the upregulation of pro-apoptotic gene 
expression and apoptosis in the tumor cells (17).
In conclusion, the present study demonstrated that the 
RNAi-mediated targeting of KLF8 suppressed CAL 27 
cell proliferation and colony number. These results also 
strongly suggest that the siRNA-mediated downregula-
tion of target gene expression is sufficiently stable in 
oral cancer cells. Furthermore, a better understanding 
of KLF8 function and processing may provide novel in-
sights into the clinical therapy of oral cancer.
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